With BioInfect taking place next week, our member video focuses on the topic of anti-microbial resistance. Yesterday Eli Lilly published details of its long-standing technology transfer programme to increase the global supply of medicines for multidrug-resistant tuberculosis (MDR-TB). Since 2003 Lilly has been donating manufacturing technology and know-how for two antibiotics, effective in treating drug-resistant strains, to pharmaceutical manufacturers in China, India, Russia and South Africa – all MDR-TB ‘hot spots’.

Watch the video to find out more about how the programme was developed and went on to form the basis for the Lilly MDR-TB Partnership.

Do you have a video you would like the sector to see? Contact us.